How to Navigate Uncertainty and Transformation in 2025
Auxilius Live Sessions
50:02
Join us for a live conversation with Lisa Delfini as she shares her perspective on how biopharma teams are navigating capital markets and transformation in 2025.
In this session we will cover:
- The evolving role of finance in the biopharma industry
- How finance teams are responding to tighter capital markets in 2025
- Lisa's experience leading finance transformations at Trevi and other organizations
- Advice for future finance leaders in life science
Hope to see you there!
The Auxilius team
Speakers
Lisa Delfini
CFO, Trevi Therapeutics
Lisa Delfini has served as Chief Financial Officer of Trevi Therapeutics since August 2021. Ms. Delfini served as a Financial Accounting and Advisory Services Partner at Marcum LLP, an accounting and advisory services company, from 2015 until August 2021, specializing in providing services to companies in the life science and high-tech industries. Previously, she worked at General Electric Company, a multinational conglomerate, as Global Controller for the GE Corporate Technical Center of Excellence from 2011 to 2014 and as Global Controller for the GE Industrial Solutions division from 2014 to 2015. Ms. Delfini began her career at Deloitte & Touche LLP, where she worked for 16 years, completing her time there as a Client Service Partner. Ms. Delfini received a B.S. in accounting from Lehigh University and is a Certified Public Accountant licensed by the state of Connecticut.
Erin Warner Guill
President & COO, Auxilius
How to Navigate Uncertainty and Transformation in 2025
50:02